These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 17465858)

  • 1. Molecular cytogenetic profiles of novel and established human anaplastic thyroid carcinoma models.
    Lee JJ; Foukakis T; Hashemi J; Grimelius L; Heldin NE; Wallin G; Rudduck C; Lui WO; Höög A; Larsson C
    Thyroid; 2007 Apr; 17(4):289-301. PubMed ID: 17465858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.
    Lee JJ; Au AY; Foukakis T; Barbaro M; Kiss N; Clifton-Bligh R; Staaf J; Borg A; Delbridge L; Robinson BG; Wallin G; Höög A; Larsson C
    Endocr Relat Cancer; 2008 Sep; 15(3):801-15. PubMed ID: 18753363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer.
    Santarpia L; El-Naggar AK; Cote GJ; Myers JN; Sherman SI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):278-84. PubMed ID: 17989125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization defines frequent loss on 16p in human anaplastic thyroid carcinoma.
    Komoike Y; Tamaki Y; Sakita I; Tomita N; Ohue M; Sekimoto M; Miyazaki M; Kadota M; Masuda N; Ooka M; Ohnishi T; Nakano Y; Kozaki T; Kobayashi T; Matsuura N; Ikeda T; Horii A; Monden M
    Int J Oncol; 1999 Jun; 14(6):1157-62. PubMed ID: 10339673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation of the PIK3CA gene in anaplastic thyroid cancer.
    García-Rostán G; Costa AM; Pereira-Castro I; Salvatore G; Hernandez R; Hermsem MJ; Herrero A; Fusco A; Cameselle-Teijeiro J; Santoro M
    Cancer Res; 2005 Nov; 65(22):10199-207. PubMed ID: 16288007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas.
    Takano T; Ito Y; Hirokawa M; Yoshida H; Miyauchi A
    Br J Cancer; 2007 May; 96(10):1549-53. PubMed ID: 17453004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
    Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
    Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis.
    Gauchotte G; Philippe C; Lacomme S; Léotard B; Wissler MP; Allou L; Toussaint B; Klein M; Vignaud JM; Bressenot A
    Pathology; 2011 Aug; 43(5):447-52. PubMed ID: 21716161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
    Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
    Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic thyroid cancer: cytogenetic patterns by comparative genomic hybridization.
    Miura D; Wada N; Chin K; Magrane GG; Wong M; Duh QY; Clark OH
    Thyroid; 2003 Mar; 13(3):283-90. PubMed ID: 12729478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ITCH is a putative target for a novel 20q11.22 amplification detected in anaplastic thyroid carcinoma cells by array-based comparative genomic hybridization.
    Ishihara T; Tsuda H; Hotta A; Kozaki K; Yoshida A; Noh JY; Ito K; Imoto I; Inazawa J
    Cancer Sci; 2008 Oct; 99(10):1940-9. PubMed ID: 19016753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity.
    Yu W; Imoto I; Inoue J; Onda M; Emi M; Inazawa J
    Oncogene; 2007 Feb; 26(8):1178-87. PubMed ID: 16924234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide appraisal of thyroid cancer progression.
    Wreesmann VB; Ghossein RA; Patel SG; Harris CP; Schnaser EA; Shaha AR; Tuttle RM; Shah JP; Rao PH; Singh B
    Am J Pathol; 2002 Nov; 161(5):1549-56. PubMed ID: 12414503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma.
    Nucera C; Eeckhoute J; Finn S; Carroll JS; Ligon AH; Priolo C; Fadda G; Toner M; Sheils O; Attard M; Pontecorvi A; Nose V; Loda M; Brown M
    Clin Cancer Res; 2009 Jun; 15(11):3680-9. PubMed ID: 19470727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.
    Pallante P; Berlingieri MT; Troncone G; Kruhoffer M; Orntoft TF; Viglietto G; Caleo A; Migliaccio I; Decaussin-Petrucci M; Santoro M; Palombini L; Fusco A
    Br J Cancer; 2005 Aug; 93(4):464-71. PubMed ID: 16106252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant BRAF splicing as an alternative mechanism for oncogenic B-Raf activation in thyroid carcinoma.
    Baitei EY; Zou M; Al-Mohanna F; Collison K; Alzahrani AS; Farid NR; Meyer B; Shi Y
    J Pathol; 2009 Apr; 217(5):707-15. PubMed ID: 19156774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy.
    Kasaian K; Wiseman SM; Walker BA; Schein JE; Zhao Y; Hirst M; Moore RA; Mungall AJ; Marra MA; Jones SJ
    BMC Cancer; 2015 Dec; 15():984. PubMed ID: 26680454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced B-Raf protein expression is independent of V600E mutant status in thyroid carcinomas.
    Kondo T; Nakazawa T; Murata S; Kurebayashi J; Ezzat S; Asa SL; Katoh R
    Hum Pathol; 2007 Dec; 38(12):1810-8. PubMed ID: 17714762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.
    Knief J; Gebauer N; Bernard V; Schemme J; Reddemann K; Gebauer J; Rades D; Brabant G; Lehnert H; Feller AC; Thorns C
    J Clin Endocrinol Metab; 2015 Feb; 100(2):754-62. PubMed ID: 25423572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.